Novartis AG Stock Swiss Exchange
Stocks
CH0012005267
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
||
| 125.45 CHF | 0.00% |
|
| 12:37pm | Swiss pharma at risk of US trade investigation, industry body says | RE |
| 11:56am | Swiss Market Index Snaps Gains; ABB Shares Down | MT |
| Market Cap | 285B 250B 230B 216B 404B 26,884B 413B 2,768B 1,071B 13,287B 1,070B 1,047B 46,073B | P/E 2026 * |
21.6x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 317B 278B 256B 240B 450B 29,924B 459B 3,082B 1,192B 14,789B 1,191B 1,165B 51,283B | EV / Sales 2026 * |
5.57x | EV / Sales 2027 * | 5.19x |
| Free-Float |
91.66% | Yield 2026 * |
2.84% | Yield 2027 * | 2.93% |
Last Transcript: Novartis AG
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.48% | +9.87% | +52.28% | +167.43% | 1,006B | ||
| +3.53% | +10.05% | +67.44% | +55.55% | 589B | ||
| +6.39% | +8.54% | +33.66% | +85.00% | 430B | ||
| -0.66% | +5.11% | +29.26% | +21.27% | 331B | ||
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | ||
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | ||
| +3.59% | +3.73% | +28.11% | +59.12% | 190B | ||
| +1.93% | +2.63% | +19.08% | +67.39% | 154B | ||
| +2.45% | -3.67% | -0.33% | -34.51% | 135B | ||
| Average | +2.49% | +4.40% | +27.16% | +45.24% | 370.63B | |
| Weighted average by Cap. | +3.66% | +4.75% | +39.27% | +78.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.92B 49.91B 46.01B 43.07B 80.76B 5,370B 82.44B 553B 214B 2,654B 214B 209B 9,202B | 60.4B 52.96B 48.82B 45.7B 85.7B 5,698B 87.48B 587B 227B 2,816B 227B 222B 9,765B |
| Net income | 14.16B 12.41B 11.44B 10.71B 20.09B 1,335B 20.5B 138B 53.21B 660B 53.16B 52B 2,289B | 15.73B 13.79B 12.71B 11.9B 22.32B 1,484B 22.78B 153B 59.13B 733B 59.07B 57.78B 2,543B |
| Net Debt | 32.23B 28.26B 26.05B 24.38B 45.73B 3,040B 46.67B 313B 121B 1,502B 121B 118B 5,210B | 28.74B 25.2B 23.23B 21.75B 40.78B 2,711B 41.63B 279B 108B 1,340B 108B 106B 4,647B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions


















